This document is an excerpt from an article detailing controversies surrounding pharmaceutical executive Mr. Hugin, a former CEO of Celgene. It highlights Celgene's aggressive drug promotion, a $280 million settlement for illegal marketing, and accusations of fighting generic competition. The text notes that these issues, particularly rising drug costs, are being used against Hugin in a political campaign by his opponent, Mr. Menendez.
Discussion 0
No comments yet
Be the first to share your thoughts on this epstein entity